| A phosphorylated pseudokinase complex controls cell wall synthesis in mycobacteria. Gee C.L., Papavinasasundaram K.G., Blair S.R., Baer C.E., Falick A.M., King D.S., Griffin J.E., Venghatakrishnan H., Zukauskas A., Wei J.R. et al.
Sci. Signal. 5:RA7-RA7(2012) · UniProtKB (3) |
| Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Andersson S., Geissler W.M., Wu L., Davis D.L., Grumbach M.M., New M.I., Schwarz H.P., Blethen S.L., Mendonca B.B., Bloise W. et al.
J. Clin. Endocrinol. Metab. 81:130-136(1996) · UniProtKB (1) |
| Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex. Marcelli M., Zoppi S., Wilson C.M., Griffin J.E., McPhaul M.J.
J. Clin. Invest. 94:1642-1650(1994) · UniProtKB (1) |
| Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. Allera A., Herbst M.A., Griffin J.E., Wilson J.D., Schweikert H.-U., McPhaul M.J.
J. Clin. Endocrinol. Metab. 80:2697-2699(1995) · UniProtKB (1) |
| Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. Marcelli M., Tilley W.D., Wilson C.M., Griffin J.E., Wilson J.D., McPhaul M.J.
Mol. Endocrinol. 4:1105-1116(1990) · UniProtKB (1) |
| Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. McPhaul M.J., Marcelli M., Tilley W.D., Griffin J.E., Isidro-Gutierrez R.F., Wilson J.D.
J. Clin. Invest. 87:1413-1421(1991) · UniProtKB (1) |
| A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance. Marcelli M., Zoppi S., Grino P.B., Griffin J.E., Wilson J.D., McPhaul M.J.
J. Clin. Invest. 87:1123-1126(1991) · UniProtKB (1) |
| Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg-->Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function. Marcelli M., Tilley W.D., Zoppi S., Griffin J.E., Wilson J.D., McPhaul M.J.
J. Clin. Endocrinol. Metab. 73:318-325(1991) · UniProtKB (1) |
| Molecular genetics of steroid 5 alpha-reductase 2 deficiency. Thigpen A.E., Davis D.L., Milatovich A., Mendonca B.B., Imperato-Mcginley J., Griffin J.E., Francke U., Wilson J.D., Russell D.W.
J. Clin. Invest. 90:799-809(1992) · UniProtKB (1) |
| Immunoreactive androgen receptor expression in subjects with androgen resistance. Wilson C.M., Griffin J.E., Wilson J.D., Marcelli M., Zoppi S., McPhaul M.J.
J. Clin. Endocrinol. Metab. 75:1474-1478(1992) · UniProtKB (1) |
| Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. McPhaul M.J., Marcelli M., Zoppi S., Wilson C.M., Griffin J.E., Wilson J.D.
J. Clin. Invest. 90:2097-2101(1992) · UniProtKB (1) |
| Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Zoppi S., Marcelli M., Deslypere J.-P., Griffin J.E., Wilson J.D., McPhaul M.J.
Mol. Endocrinol. 6:409-415(1992) · UniProtKB (1) |
